Showing results (2681-2690 of 9,180) with videos related to

Sort By:
Pageof 918
Cancer Medicine|December 8, 2023
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: A systematic review and meta-analysisXin Gao, Ying Zhu, Peipei Wang, et al.
Cancer Medicine|December 8, 2023
Beyond the horizon: Neutrophils leading the way in the evolution of immunotherapySanjana Rajgopal, Kosuke Nakano, Leah M Cook
Cancer Medicine|December 1, 2023
HS-10352 in hormone receptor-positive, HER2-negative advanced breast cancer: A phase 1 dose-escalation trialQuchang Ouyang, Ying Wang, Jian Zhang, et al.
Cancer Medicine|December 1, 2023
Anti-inflammatory mechanisms in cancer research: Characterization of a distinct M2-like macrophage model derived from the THP-1 cell lineKatharina M Scheurlen, Dylan L Snook, Andrew B Littlefield, et al.
Cancer Medicine|November 29, 2023
Allogeneic hematopoietic stem cell transplantation for B-cell lymphoma in TaiwanChun-Hui Lee, Tzu-Chien Lin, Ming Yao, et al.
Cancer Medicine|November 28, 2023
Development and validation of a novel nomogram predicting clinically significant prostate cancer in biopsy-naive men based on multi-institutional analysisQingyu Ge, Sicong Zhang, Hewei Xu, et al.
Cancer Medicine|November 28, 2023
Increased STX3 transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patientsTakahiro Shinozuka, Mitsuro Kanda, Yusuke Sato, et al.
Cancer Medicine|November 27, 2023
Prediction of attributable mortality in pediatric patients with cancer admitted to the intensive care unit for suspected infection: A comprehensive evaluation of risk scoresZachary Rubnitz, Yilun Sun, Asya Agulnik, et al.
Cancer Medicine|November 21, 2023
Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinomaShengjian Jin, Takaaki Tsunematsu, Taigo Horiguchi, et al.
Cancer Medicine|November 22, 2023
The efficacy and safety of chemotherapy with or without anti-PD-1 for the first-line treatment of advanced urothelial carcinomaFuxin Han, Zhaozhen Wu, Jiaxin Chen, et al.
Pageof 918